iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments.

iCAD, Inc. ( NASDAQ:ICAD ) is possibly approaching a major achievement in its business, so we would like to shine some... iCAD ( NASDAQ:ICAD ) Full Year 2024 Results Key Financial Results Revenue ...

ICAD ($ICAD) is expected to release its quarterly earnings data on Wednesday, March 19th after market close, per Finnhub. Analysts are expecting revenue of $4,924,050 ...

Greetings. Welcome to the iCAD Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session ...

iCAD partners with RamSoft to integrate AI-powered ... to leverage comprehensive cloud-based RIS (Radiology Information System)/PACS (Picture Archiving and Communication System) capabilities.

To accomplish this, NIA selected global technology firm ICAD Holding as its master system integrator (MSI) consultant and partnered with Indian IT major Wipro which will act as a sub-consultant to ...

Shares of iCAD stock opened at $2.24 on Friday. The firm has a market capitalization of $59.45 million, a PE ratio of -17.23 and a beta of 1.95. The business’s 50-day moving average price is $2. ...

Net Cash Used for Operating Activities: $3.9 million for the full-year 2024. ICAD Inc (NASDAQ:ICAD) reported strong revenue growth, with Q4 2024 revenue reaching $5.4 million, a 14% increase over ...

Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The ...

NASHUA, N.H. (AP) — NASHUA, N.H. (AP) — Icad inc. (ICAD) on Wednesday reported a loss of $854,000 in its fourth quarter. The Nashua, New Hampshire-based company said it had a loss of 3 cents ...